Status:
COMPLETED
Remifentanil as Intravenous Patient-controlled Analgesia (IVPCA) During Labour
Lead Sponsor:
Sorlandet Hospital HF
Conditions:
Labour Pain
Satisfaction
Eligibility:
FEMALE
Phase:
PHASE4
Brief Summary
Remifentanil is a ultra short-acting synthetic opioid. It is rapidly metabolized by non-specific blood and tissue esterases. We wanted to investigate the efficacy and safety of remifentanil used as an...
Detailed Description
Primary and secondary outcome measures presented under "results"
Eligibility Criteria
Inclusion
- Healthy women (ASA I-II), in active labour, one fetus with no suspected pathology, expecting normal childbirth, informed consent.
Exclusion
- Failure to obtain informed consent, received opioids within last 8 hours before study start, serious side-effects mother and abnormal fetal heart rate.
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT00202722
Start Date
January 1 2004
End Date
August 1 2007
Last Update
June 23 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sorlandet sykehus HF
Kristiansand, Vest-Agder, Norway, N-4623